Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

IO Biotech · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
chemotherapyimmunotherapynsclcpembrolizumab
nsclc, pd-1, pd-l1, programmed cell death 1, chemotherapy, pemetrexed, carboplatin, pembrolizumab, immunotherapy, io102, keytruda, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 851540
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.